Previous 10 | Next 10 |
Small cap growth stocks have entered bear market territory, pressured by significant multiple compression from higher interest rates and unfolding economic deceleration. The Strategy underperformed in a difficult market, with declines most pronounced among several long-term holdings i...
AngioDynamics posted better sales growth in FQ4'22 as elective procedure counts continue to rebound, but margin pressures continue to weigh significantly. The company is building a sustainable core growth story, with multiple opportunities to gain share and grow addressable markets in...
Penumbra, Inc. Schedules Second Quarter 2022 Earnings Release and Conference Call for August 4, 2022 PR Newswire ALAMEDA, Calif. , July 7, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss finan...
Fundamentally, Penumbra presents with the product economics and above-market sales trajectory to unlock long-term value. The stock has underperformed recently, yet, the value proposition in its operating segments remains. Despite this it remains exorbitantly valued, and we see mul...
Penumbra, Inc. (PEN) Q1 2022 Earnings Conference Call May 3, 2022 4:30 PM ET Company Participants Jee Hamlyn-Harris – Investor Relations Adam Elsesser – Chairman and Chief Executive Officer Maggie Yuen – Chief Financial Officer Jason Mills – Executive Vice Presiden...
Penumbra press release (NYSE:PEN): Q1 Non-GAAP EPS of -$0.01 misses by $0.05. Revenue of $203.9M (+20.5% Y/Y) beats by $8.51M. For further details see: Penumbra Non-GAAP EPS of -$0.01 misses by $0.05, revenue of $203.9M beats by $8.51M
Penumbra, Inc. Reports First Quarter 2022 Financial Results PR Newswire ALAMEDA, Calif. , May 3, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first q...
Penumbra, Inc. to Present at the Bank of America Securities 2022 Healthcare Conference PR Newswire ALAMEDA, Calif. , April 26, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Ban...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Small cap growth stocks entered bear market territory dur...
Penumbra (NYSE:PEN) said its Indigo Aspiration System with Lightning 7 and Lightning 12 secured CE Mark (Conformité Européenne) and are now commercially available in Europe. The company said both technologies are part of its Indigo Aspiration System – now with Intelligen...
News, Short Squeeze, Breakout and More Instantly...
2024-07-13 17:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-03 18:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024 PR Newswire ALAMEDA, Calif. , July 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial resu...